ZA201100199B - Use and methods for preventing and/or treating oral malodour - Google Patents

Use and methods for preventing and/or treating oral malodour

Info

Publication number
ZA201100199B
ZA201100199B ZA2011/00199A ZA201100199A ZA201100199B ZA 201100199 B ZA201100199 B ZA 201100199B ZA 2011/00199 A ZA2011/00199 A ZA 2011/00199A ZA 201100199 A ZA201100199 A ZA 201100199A ZA 201100199 B ZA201100199 B ZA 201100199B
Authority
ZA
South Africa
Prior art keywords
preventing
methods
treating oral
oral malodour
malodour
Prior art date
Application number
ZA2011/00199A
Other languages
English (en)
Inventor
Mewes Bottner
Christine Lang
Markus Veen
Michael Schilling
Andreas Reindl
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of ZA201100199B publication Critical patent/ZA201100199B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/23Lactobacillus acidophilus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/24Lactobacillus brevis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/245Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ZA2011/00199A 2008-06-11 2011-01-07 Use and methods for preventing and/or treating oral malodour ZA201100199B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08010641A EP2133414A1 (en) 2008-06-11 2008-06-11 Uses and methods for preventing and /or treating oral malodour
PCT/EP2009/003586 WO2009149816A1 (en) 2008-06-11 2009-05-19 Use and methods for preventing and/or treating oral malodour

Publications (1)

Publication Number Publication Date
ZA201100199B true ZA201100199B (en) 2012-03-28

Family

ID=39940682

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/00199A ZA201100199B (en) 2008-06-11 2011-01-07 Use and methods for preventing and/or treating oral malodour

Country Status (12)

Country Link
US (1) US8506953B2 (enExample)
EP (2) EP2133414A1 (enExample)
JP (1) JP5732387B2 (enExample)
KR (1) KR101648992B1 (enExample)
CN (2) CN102057036B (enExample)
AU (1) AU2009256978B2 (enExample)
CA (1) CA2724769A1 (enExample)
ES (1) ES2574135T3 (enExample)
PL (1) PL2300598T3 (enExample)
RU (2) RU2515113C2 (enExample)
WO (1) WO2009149816A1 (enExample)
ZA (1) ZA201100199B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014007972A2 (en) 2012-06-15 2014-01-09 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinphrine
EP3424516A1 (en) 2011-01-24 2019-01-09 Basf Se Oral health improving compositions
CA2831345C (en) 2011-05-06 2022-05-03 Organobalance Medical Ag Lactic acid bacterial strains that coaggregate with staphylococcus aureus, and compositions and uses of the strains
US9308227B2 (en) 2011-05-16 2016-04-12 Organobalance Medical Ag Lactic acid bacteria and compositions containing them against bacterial colds
DE102011116325B4 (de) 2011-10-14 2016-03-10 orochemie GmbH + Co. KG Neue Milchsäurebakterien und diese enthaltende Zusammensetzungen
EP2787953A2 (en) * 2011-12-06 2014-10-15 Unilever PLC, a company registered in England and Wales under company no. 41424 Hair colour composition
US9339453B2 (en) * 2012-02-24 2016-05-17 Nowsystem, Inc. Compositions and related methods for oral wellness
JP5421478B1 (ja) * 2012-04-18 2014-02-19 幸子 又吉 老化対策健康飲食品とその製造方法
ES2882530T3 (es) 2013-03-22 2021-12-02 Univ Nova Southeastern Partículas finas de epinefrina y métodos para uso de las mismas para el tratamiento de condiciones que responden a la epinefrina
US20160193302A1 (en) * 2013-09-02 2016-07-07 Nestec S.A. Lactoferrin and memory and learning speed in children
US9585820B2 (en) 2014-05-20 2017-03-07 Avon Products, Inc. Laponite clay in cosmetic and personal care products
JP6463939B2 (ja) * 2014-10-14 2019-02-06 株式会社ブロマ研究所 免疫機能調整口腔剤
MX369506B (es) * 2014-12-16 2019-11-11 Colgate Palmolive Co Composiciones de sales metálicas.
KR101596241B1 (ko) 2015-07-15 2016-02-23 주식회사한국야쿠르트 구취를 억제하는 활성을 갖는 스트렙토코커스 써머필러스 hy9012를 유효성분으로 함유하는 조성물
CN107058175B (zh) * 2017-03-14 2020-04-03 中国疾病预防控制中心传染病预防控制所 唾液链球菌及在制备去除口臭药物中的应用
JP2019025011A (ja) * 2017-07-31 2019-02-21 株式会社グリーンエッセンス フロスホルダー及びフロス
CN107410479B (zh) * 2017-09-06 2023-12-08 光明乳业股份有限公司 一种发酵乳及其制备方法
US12246078B2 (en) 2017-09-14 2025-03-11 Gerald P. Curatola Oral care formulations and methods for use
CN107865891B (zh) * 2017-11-06 2020-04-28 四川大学 一种益生菌组合物、制剂、菌泥和用途
RU2691410C1 (ru) * 2018-04-26 2019-06-13 Федеральное государственное бюджетное учреждение науки "Институт морских биологических исследований имени А.О. Ковалевского РАН" Средство для ухода за полостью рта и горла
WO2020081952A1 (en) * 2018-10-19 2020-04-23 Nova Southeastern University Sublingual epinephrine compositions including ph-modifying excipients and penetration enhancers and methods for use thereof
CN109943509A (zh) * 2019-04-12 2019-06-28 沈阳药科大学 一种利用全单质培养基高密度培养乳酸菌的方法
CN111471628B (zh) * 2020-06-04 2022-02-15 内蒙古农业大学 一株新的链球菌及其制剂在抑制口腔致病菌中的应用
KR102360233B1 (ko) * 2021-03-26 2022-02-09 (주)바이오일레븐 구강질환 예방 또는 개선 효과를 가지는 락토바실러스 퍼멘텀 균주 및 이의 용도
CN113913348B (zh) * 2021-11-25 2023-06-30 云南中烟工业有限责任公司 一种格氏克雷伯氏菌sa34及其应用
US20240091135A1 (en) * 2022-09-17 2024-03-21 Reshma N. Kheraj Compositions and methods for promoting oral health
WO2024224392A1 (en) * 2023-04-23 2024-10-31 Ultraoral Ltd. Thermal energy system for administering active agents
CN118370807B (zh) * 2024-04-26 2025-02-14 河南智原和诺科技有限公司 一种抑制牙龈卟啉单胞菌的组合物及其制备方法和应用

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946725A (en) 1957-03-25 1960-07-26 Procter & Gamble Dentifrice compositions
US3678154A (en) 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
BE757004A (fr) 1969-10-03 1971-03-16 Gore & Ass Agent d'etancheite
CA962021A (en) 1970-05-21 1975-02-04 Robert W. Gore Porous products and process therefor
US3962153A (en) 1970-05-21 1976-06-08 W. L. Gore & Associates, Inc. Very highly stretched polytetrafluoroethylene and process therefor
US3800812A (en) 1972-11-27 1974-04-02 Pauldan Ind Inc Dental floss and method of making same
US3959458A (en) 1973-02-09 1976-05-25 The Procter & Gamble Company Oral compositions for calculus retardation
US3937807A (en) 1973-03-06 1976-02-10 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US4096227A (en) 1973-07-03 1978-06-20 W. L. Gore & Associates, Inc. Process for producing filled porous PTFE products
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
US4083955A (en) 1975-04-02 1978-04-11 The Procter & Gamble Company Processes and compositions for remineralization of dental enamel
US4051234A (en) 1975-06-06 1977-09-27 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US4206215A (en) 1976-02-25 1980-06-03 Sterling Drug Inc. Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes
JPS52154590A (en) 1976-05-21 1977-12-22 Seikenkai Cultivating and preserving method of deodorising lactobucillus and liling cell preparation
US4256806A (en) 1979-07-05 1981-03-17 W. L. Gore & Associates, Inc. Smudge free graphite coated polymeric substrate and a method for preparing the same
US4478665A (en) 1980-11-06 1984-10-23 W. L. Gore & Associates, Inc. Method for manufacturing highly porous, high strength PTFE articles
US4385093A (en) 1980-11-06 1983-05-24 W. L. Gore & Associates, Inc. Multi-component, highly porous, high strength PTFE article and method for manufacturing same
US4885155A (en) 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
US4849213A (en) 1983-03-01 1989-07-18 Schaeffer Hans A Dental preparation, article and method for storage and delivery therof
JPS6030686A (ja) 1983-07-30 1985-02-16 Yakult Honsha Co Ltd 乳酸桿菌属の細菌に供与dνaを導入する方法
EP0154549B1 (en) * 1984-03-09 1990-12-27 Kabushiki Kaisya Advance Anticariogenic or antiperiodontitic agent
DE3645147C2 (de) 1985-09-13 2000-11-09 Colgate Palmolive Co Zahnpflegemittel
US4918014A (en) 1985-10-11 1990-04-17 Microlife Technics, Inc. Method for producing mucoid and phage resistant group N streptococcus strains from non-mucoid and phage sensitive parent strains
FI77056C (fi) 1986-06-24 1989-01-10 Valio Meijerien Vektorplasmid som laempar sig foer syrningsmedel, speciellt foer mejerisyrningsmedel.
US4776358A (en) 1986-09-23 1988-10-11 Leonard Lorch Floss employing microporous tapes sandwiching paste dentifrice
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
EP0311469A3 (en) 1987-09-02 1990-05-30 Plant Genetic Systems N.V. Transformed lactic acid bacteria
US5004597A (en) 1987-09-14 1991-04-02 The Procter & Gamble Company Oral compositions comprising stannous flouride and stannous gluconate
EP0316677A3 (en) 1987-11-13 1990-04-25 Miles Inc. Method for cloning in lactic acid bacteria
US5209251A (en) 1988-03-29 1993-05-11 Colgate-Palmolive Company Dental floss
US5033488A (en) 1988-03-29 1991-07-23 Colgate-Palmolive Co. Dental floss
GB8912316D0 (en) * 1989-05-30 1989-07-12 Shell Int Research Coal gasification reactor
US4974615A (en) 1989-07-26 1990-12-04 Doundoulakis George J Elastic filament for oral hygiene
NZ235489A (en) 1989-10-16 1992-03-26 Colgate Palmolive Co Articles for therapeutic (e.g. dental) use having a polytetrafluoroethylene surface which is coated with an adjuvant and a partially water-soluble binder
WO1991009131A1 (en) 1989-12-20 1991-06-27 Valio Finnish Cooperative Dairies Association Cloning vector for use in lactic acid bacteria
US5884639A (en) 1996-03-08 1999-03-23 Applied Elastomerics, Inc. Crystal gels with improved properties
US5760117A (en) 1990-05-21 1998-06-02 Applied Elastomerics, Inc. Gelatinous composition and articles
US5015466A (en) 1990-06-26 1991-05-14 The Procter & Gamble Company Anticalculus compositions using tartrate-succinates
US5220932A (en) 1990-12-20 1993-06-22 Westone Products Limited Dental floss and method of making it
US5281410A (en) 1991-10-23 1994-01-25 The Proctor & Gamble Company Methods of reducing plaque and gingivitis with reduced staining
US5213790A (en) 1991-10-23 1993-05-25 The Procter & Gamble Co. Methods of reducing plaque and gingivitis with reduced staining
US5145666A (en) 1991-10-23 1992-09-08 The Proctor & Gamble Co. Methods of reducing plaque and gingivitis with reduced staining
GB9126686D0 (en) 1991-12-17 1992-02-12 Smithkline Beecham Plc Novel compositions
US5407623A (en) 1994-01-06 1995-04-18 Polteco, Inc. Process for obtaining ultra-high modulus line products with enhanced mechanical properties
US5433226A (en) 1994-03-09 1995-07-18 Delta Dental Hygienics, L.L.C. Dental floss based on robust segmented elastomer
US5518012A (en) 1994-06-15 1996-05-21 W. L. Gore & Associates, Inc. Expanded PTFE floss material and method of making same
US6027592A (en) 1995-06-06 2000-02-22 Gillette Canada Inc. Dental floss
US5718251A (en) 1996-04-26 1998-02-17 W. L. Gore & Associates, Inc. Dental floss article
US5755243A (en) 1996-06-27 1998-05-26 Gillette Canada, Inc. Dental floss with thermoplastic coating
US5911228A (en) 1996-07-10 1999-06-15 Colgate-Palmolive Co. Ingredient filled polytetrafluoroethylene dental floss devoid to grip enhancing coating
KR100266752B1 (ko) * 1997-08-07 2001-03-02 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6003525A (en) 1998-03-14 1999-12-21 Katz; Harry S. Elastomer floss and related flossing devices
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
US6270781B1 (en) 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
EP1038951A1 (en) 1999-03-23 2000-09-27 Societe Des Produits Nestle S.A. Synthetic medium for cultivating lactobacillus and/or bifidobacteria
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
ATE419331T1 (de) 2000-08-25 2009-01-15 Wakamoto Pharma Co Ltd L. salivarius-stamm enthaltende probiotische produkte
DE10101294A1 (de) 2001-01-12 2002-07-18 Rotta Gmbh Zusammensetzung zur Stabilisierung von Cyclodextrin-Flotten
US6591844B2 (en) 2001-01-22 2003-07-15 Peri-Deat Limited Elastomeric monofilament dental tapes
JP2004533859A (ja) 2001-01-22 2004-11-11 インターナシヨナル・テープ・パートナーズ・エル・エル・シー エラストマー単繊維デンタルテープ用の結晶を含まない唾液溶解性コーティング
ES2276728T3 (es) * 2001-02-23 2007-07-01 Chemisches Laboratorium Dr. Kurt Richter Gmbh Composicion de uso topico.
AU2002243023A1 (en) * 2001-04-02 2002-10-21 Wakamoto Pharmaceutical Co., Ltd. Compositions for preventing and/or treating oral diseases
US6770264B2 (en) 2001-11-13 2004-08-03 Noville, Inc. Chewing gum compositions comprising diglycerol
KR100356672B1 (ko) 2001-12-27 2002-10-19 주식회사 바이로박트 신규한 락토바실러스 속 미생물 및 그 용도
EP1483366B1 (en) * 2002-02-22 2010-04-14 Blis Technologies Limited Antimicrobial composition
AU2002243005A1 (en) 2002-03-29 2003-10-13 Frente International Co., Ltd. Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
US20040101495A1 (en) * 2002-11-27 2004-05-27 Leena Nase Method for improving dental health
US6872565B2 (en) 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
AU2004257553C1 (en) * 2003-07-18 2011-11-10 Blis Technologies Limited Treatment of malodour
US20060018843A1 (en) 2004-07-24 2006-01-26 Fine Kenneth D Halitosis, gingivitis, and periodontitis treatment and preventative composition
KR100605992B1 (ko) * 2004-08-25 2006-07-28 전남대학교산학협력단 구취를 억제하는 유산균
EP1634948A1 (en) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
AU2006291480A1 (en) * 2005-09-13 2007-03-22 Basf Se Microorganisms inhibiting the formation of axillary malodor
JP2009522330A (ja) 2006-01-04 2009-06-11 マウデ ウィクストレム, 微生物の成長を刺激する口内用健康促進生成物

Also Published As

Publication number Publication date
AU2009256978A1 (en) 2009-12-17
RU2515113C2 (ru) 2014-05-10
CN104277998A (zh) 2015-01-14
EP2300598A1 (en) 2011-03-30
ES2574135T3 (es) 2016-06-15
EP2133414A1 (en) 2009-12-16
JP2011525351A (ja) 2011-09-22
US20110097284A1 (en) 2011-04-28
KR101648992B1 (ko) 2016-08-17
CN102057036A (zh) 2011-05-11
JP5732387B2 (ja) 2015-06-10
CA2724769A1 (en) 2009-12-17
WO2009149816A1 (en) 2009-12-17
CN104277998B (zh) 2021-02-02
RU2743057C2 (ru) 2021-02-15
BRPI0914726A2 (pt) 2015-10-20
RU2010154397A (ru) 2012-07-20
RU2014106603A (ru) 2015-08-27
AU2009256978B2 (en) 2015-07-30
PL2300598T3 (pl) 2016-10-31
US8506953B2 (en) 2013-08-13
CN102057036B (zh) 2017-11-17
KR20110019420A (ko) 2011-02-25
EP2300598B1 (en) 2016-04-13

Similar Documents

Publication Publication Date Title
ZA201100199B (en) Use and methods for preventing and/or treating oral malodour
HRP20182135T1 (hr) Pripravci za i postupci liječenja poremećaja povezanih s ige
IL202015A0 (en) Methods and compositions for treating skin conditions
PL2894165T3 (pl) Sposoby i kompozycje do leczenia zaburzeń układu dopełniacza
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
IL209895A (en) Compounds for the prevention and / or treatment of β-amyloidoses
EP2382010A4 (en) METHOD AND SYSTEMS FOR FAT REDUCTION AND / OR TREATMENT OF CELLULITE
IL211816A0 (en) Airflow applicators and related treatment methods
EP2262450A4 (en) IMPLANTS AND METHODS OF USE
IL212079A0 (en) Methods and devices for treating sleep apnea
SG10201408158SA (en) Composition and methods used during anti-hiv treatment
IL209032A0 (en) Compositions and methods for treating digestive disorders
ZA201006293B (en) Composition and method for seed treatment use
PL2271218T3 (pl) Zastosowanie i kompozycja do leczenie otępienia
IL210097A0 (en) Compositions and methods for treating unfluenza
IL198723A0 (en) Methods and compositions for therapeutic treatment
GB0718918D0 (en) Compositions and methods for treating skin conditions
GB0604471D0 (en) Device and method for the treatment of tumours
GB0816650D0 (en) Therapeutic bone grwth and regeneration
EP2198041A4 (en) METHOD AND COMPOSITION FOR CANCER DIAGNOSIS AND TREATMENT
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD
ZA201009066B (en) Materials and methods for suppressing and/or treating neurofibroma and related tumors
GB0714500D0 (en) composition and treatment
EP2162084A4 (en) METHOD AND DEVICE FOR TREATMENT OF TISSUE
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia